View Older Stories View More Recent Stories
-
Green Rise Foods Provides Update on Strategic Review, Amended Credit Agreement, $1.581 Million Capital Injection and Production Update
-
SpaceX reports earnings today: What analysts say matters most for the SPCX stock
-
Dominion Lending Centres Acquires Filogix, a Leading Canadian Mortgage Technology and Connectivity Platform
-
Rise Nano Optics Uplists to OTCQB Venture Market and Achieves DTC Eligibility, Expanding Access to U.S. Investors
-
TNL Mediagene and Miro Bring AI-Powered Organizational Design Services to Enterprise Clients in Japan
-
ESSE Care Hosts Second Annual Summer Soirée, Celebrating the Partnerships Advancing Endometriosis and Fertility Care
-
F4 Begins Search for Radioactive Boulders at Todd and Wales Lake
-
Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL
-
Forsys Welcomes John Borshoff as CEO and Announces AGM Voting Results
-
Strathmore Prioritizes Agate Project Mineral Resource Development
-
RUA GOLD Receives Approval to Commence Exploration Drilling at the Glamorgan Project on New Zealand's North Island
-
TempraMed Announces Strategic Partnership with Stealth Health, a Leading Telemedicine Platform for Longevity and Wellness
-
Datadog (DDOG) PT Raised to $295 at Canaccord
-
European Building Materials Celebrates Two RIBA Regional Award Wins for 2026
-
Critical One Energy Engages Micon International for Howells Lake Antimony-Gold Project Resource Definition
-
JFrog (FROG) PT Raised to $95 at Canaccord
-
Toyota Motor Corporation (TM) Tops Q2 EPS by 319c
-
Stoke Therapeutics (STOK) PT Lowered to $58 at Canaccord
-
Ametek (AME) Tops Q2 EPS by 10c ; Offers Guidance
-
Needham Starts SK Hynix (SKHY) at Buy
-
USA Compression Partners (USAC) Tops Q2 EPS by 1c
-
Vertex (VRTX) PT Raised to $442 at Canaccord
-
Abbvie (ABBV) PT Raised to $288 at Guggenheim
-
Ultragenyx Pharma (RARE) PT Lowered to $35 at Guggenheim
-
H.C. Wainwright Reiterates Buy Rating on Seaport Therapeutics (SPTX)
-
H.C. Wainwright Reiterates Buy Rating on Compugen (CGEN)
-
H.C. Wainwright Reiterates Buy Rating on Keros Therapeutics (KROS)
-
United Parks & Resorts Inc. (PRKS) Misses Q2 EPS by 35c
-
Rosenblatt Assumes Lattice Semiconductor (LSCC) at Buy
-
5E Advanced Materials (FEAM) PT Lowered to $3.50 at H.C. Wainwright
-
Oppenheimer 'Tactically' Upgrades Inspire Medical Systems (INSP) to Outperform 'Despite Noisy Fundamentals'
-
Tempus AI Inc (TEM) PT Lowered to $56 at H.C. Wainwright
-
TG Therapeutics (TGTX) PT Raised to $78 at H.C. Wainwright
-
Kimco Realty (KIM) Tops Q2 EPS by 2c
-
Senmiao Technology hires advisor for AI data center government relations
-
ScottsMiracle-Gro sets fiscal 2027-2029 financial targets at investor day
-
Rosenblatt Starts SK Hynix (SKHY) at Buy
-
Needham Starts Vishay Intertechnology (VSH) at Buy
-
Stevanato Group S.p.A. (STVN) Tops Q2 EPS by 1c
-
Willis Lease Finance (WLFC) Misses Q2 EPS by 195c
-
MPLX LP (MPLX) Misses Q2 EPS by 1c
-
GeneDx (WGS) PT Raised to $90 at Canaccord
-
Haverty (HVT) Misses Q2 EPS by 3c
-
Spotify falls on second quarter earnings miss
-
Pfizer (PFE) Tops Q2 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
-
Marathon Petroleum (MPC) Tops Q2 EPS by 479c
-
BofA says this memory stock could double. Here are 5 reasons why
-
Aptiv (APTV) Tops Q2 EPS by 21c ; Offers Guidance
-
Merck shares rise on big Q2 earnings beat, adjusted FY outlook
-
Caterpillar stock jumps on strong earnings and revenue beat
